Big Sioux Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Big Sioux Wealth Management's JAZZ Position: Q3 2026 in Review
Big Sioux Wealth Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2026, closing a stake of 7 shares — an estimated $1.69K sold.
Big Sioux Wealth Management first reported a position in JAZZ in Q4 2025 and held it in 3 quarters. The position peaked at $1.69K in Q2 2026. 672 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Big Sioux Wealth Management reported no remaining Jazz Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Big Sioux Wealth Management sold 7 Jazz Pharmaceuticals shares in Q3 2026, an estimated $1.69K.
- Big Sioux Wealth Management first reported a position in Jazz Pharmaceuticals in Q4 2025 and held it in 3 quarters.
- Big Sioux Wealth Management's Jazz Pharmaceuticals position peaked at $1.69K in Q2 2026.
- 672 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Big Sioux Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.